Mangiferin in combination with primaquine reduces disease progression and transmission potential while alleviating cerebral pathology through suppression of neural cell apoptosis in experimental cerebral malaria.
- DOI
- 10.1007/s10787-026-02330-2
- Published
- 2026 Aug
- Container
- Inflammopharmacology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10787-026-02330-2,
title = {Mangiferin in combination with primaquine reduces disease progression and transmission potential while alleviating cerebral pathology through suppression of neural cell apoptosis in experimental cerebral malaria.},
author = {Halder S and Mukherjee S and Ghosh S and Khamaru P and Choudhury A and Ghosh P and Daptary AH and Brahma S and Sengupta A and Chatterjee B and Bhattacharyya A},
year = {2026},
journal = {Inflammopharmacology},
doi = {10.1007/s10787-026-02330-2},
url = {https://doi.org/10.1007/s10787-026-02330-2}
}RIS
TY - JOUR TI - Mangiferin in combination with primaquine reduces disease progression and transmission potential while alleviating cerebral pathology through suppression of neural cell apoptosis in experimental cerebral malaria. AU - Halder S AU - Mukherjee S AU - Ghosh S AU - Khamaru P AU - Choudhury A AU - Ghosh P AU - Daptary AH AU - Brahma S AU - Sengupta A AU - Chatterjee B AU - Bhattacharyya A PY - 2026 JO - Inflammopharmacology DO - 10.1007/s10787-026-02330-2 UR - https://doi.org/10.1007/s10787-026-02330-2 ER -
APA
S, H., S, M., S, G., P, K., A, C., P, G., AH, D., S, B., A, S., B, C., & A, B. (2026). Mangiferin in combination with primaquine reduces disease progression and transmission potential while alleviating cerebral pathology through suppression of neural cell apoptosis in experimental cerebral malaria.. Inflammopharmacology. https://doi.org/10.1007/s10787-026-02330-2
Source records
- pubmed · retrieved 2026-09-25T12:25:33.357Z
- europe-pmc · retrieved 2026-09-25T12:25:33.384Z